A Randomized, Double-Blind, Placebo-Controlled, and Multiple Dose Study for participants with Duchenne Muscular Dystrophy

Study Title

A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study with an Open-Label Extension to Determine the Safety, Pharmacokinetics and Efficacy of Oral Ifetroban in Subjects with Duchenne Muscular Dystrophy” 

Study Description

A study of the drug Ifetroban in males with Duchenne Muscular Dystrophy. 

Study Eligibility

Diagnosis of Duchenne Muscular Dystrophy (DMD), male and a stable dose of oral corticosteroids.